Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IPS Appoints Bigelow to Board | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

IPS Appoints Bigelow to Board

Bigelow joins Lavin as external member

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

IPS-Integrated Project Services has appointed two new members to its board of directors, Peter T. Bigelow and Cliff Lavin. Mr. Bigelow is the chief executive officer of xCell Strategic Consulting, a global strategic development and operations improvement solutions firm. He previously served as president for North America Commercial Operations at Patheon and also held the position of interim chief executive officer at the company. Prior to joining Patheon, Mr. Bigelow held leadership roles with increasing responsibilities for global operations with Wyeth.
 
“Peter and Cliff both bring proven management expertise, outstanding business acumen and a wide-range of experience to IPS”, said Dave Goswami, PE, chief executive officer and managing director of IPS. “Peter’s knowledge of the biopharmaceutical industry and Cliff’s business acumen will be of tremendous value as we continue to develop our short- and long-term plans. Peter is an industry recognized, experienced Fortune 500 executive with extensive global experience and has a true understanding of the issues facing global biopharmaceutical manufacturing companies in the U.S. and emerging countries. Cliff has executive experience in global industries not related to biopharmaceuticals. We believe that the diverse experiences of Peter and Cliff will be an invaluable asset as our growth takes us to uncharted territory.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters